Viewing Study NCT01041859


Ignite Creation Date: 2025-12-24 @ 3:01 PM
Ignite Modification Date: 2026-01-25 @ 8:49 PM
Study NCT ID: NCT01041859
Status: COMPLETED
Last Update Posted: 2013-09-11
First Post: 2009-12-30
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate the Efficacy, Safety, and Tolerability of Tapentadol ER Compared With Placebo in Patients With Chronic, Painful Diabetic Peripheral Neuropathy
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetic Peripheral Neuropathy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Diabetic Peripheral Neuropathy View
None Painful View
None Polyneuropathy View
None Peripheral neuropathy View